Skip to content
Unrated Drug recall · FDA · Published May 28, 2025

Apotex Ketorolac Ophthalmic Solution Recall: Lack of Sterility Assurance

Apotex recalls Ketorolac 0.5% eye drops due to lack of sterility assurance. This could cause infections. Check NDC 60505-1003-2, batch TZ1236, exp 11/30/2025.

🇺🇸 FDA recall #D-0494-2025DrugApotex ›
Take action

Contact the company

Recalling firmApotex Corp.2400 N Commerce Pkwy Ste 400 · Weston, FL 33326-3253
✎ GovInfoNow plain-language explainer

What happened, in plain English

Apotex is recalling Ketorolac Tromethamine Ophthalmic Solution 0.5% 10mL eye drops because they may not be sterile. This could lead to eye infections if used. The recall applies to prescription-only products with specific batch and expiration details. Read more at govinfonow.com/recall/32045-apotex-ketorolac-ophthalmic-solution-recall-lack-of-sterility-assurance.

Source Summary by GovInfoNow · govinfonow.com/recall/32045-apotex-ketorolac-ophthalmic-solution-recall-lack-of-sterility-assurance · Updated August 17, 2026 · FDA enforcement record: FDA #D-0494-2025

Cite this page

“Apotex Ketorolac Ophthalmic Solution Recall: Lack of Sterility Assurance.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32045-apotex-ketorolac-ophthalmic-solution-recall-lack-of-sterility-assurance. Based on FDA recall #D-0494-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0494-2025%22&limit=1).

Why it’s dangerous

The product may not be sterile, which can lead to eye infections. This is a serious risk for people using the medication as prescribed.

Who’s affected

Prescription users of Ketorolac eye drops with the specific NDC 60505-1003-2 and batch TZ1236. People with eye conditions requiring this medication are most at risk.

How to tell if you have this one

Check for the NDC code 60505-1003-2 and batch number TZ1236 on the label. The expiration date is November 30, 2025. This product is prescription-only.

  • Brand
    Apotex
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US Nationwide.
Recall numberProduct, codes & lotsQuantityNDC
D-0494-2025Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-2; Batch TZ1236, Exp Date: 11/30/202587,840 bottles60505-1003-1, 60505-1003-2
D-0495-2025Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, Rx Only, Sterile, Mfg. by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0578-4; Batch VD1654, Exp Date: 06/30/2027105,456 Bottles60505-0578-4
D-0496-2025Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, 15 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-3; Batch VC6058, Exp Date: 10/31/20256,288 Bottles60505-0589-1, 60505-0589-2, 60505-0589-3
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC 60505-1003-2 and batch TZ1236 on the label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 35 days after the firm started it.

1. Firm started the recall: May 28, 202512. FDA classified it Class II: Jun 25, 202523. Published in FDA’s Enforcement Report: Jul 2, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall states there is a lack of sterility assurance, so it may not be safe. Do not use until you confirm it's not recalled.

Similar recalls

Other Apotex recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0494-2025 (May 28, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0494-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA